共 271 条
[1]
Torres T(2019)Update on atopic dermatitis Acta Med Port 32 606-613
[2]
Ferreira EO(2013)New insights into atopic dermatitis: role of skin barrier and immune dysregulation Allergol Int 62 151-161
[3]
Goncalo M(2012)Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 132 949-963
[4]
Mendes-Bastos P(2021)Integrated Chinese and western medicine interventions for atopic dermatitis: a systematic review and meta-analysis Chin Med-UK 16 101-37
[5]
Selores M(2017)Atopic dermatitis: pathophysiology Adv Exp Med Biol 1027 21-166
[6]
Filipe P(2021)A TCM formula VYAC ameliorates DNCB-induced atopic dermatitis via blocking mast cell degranulation and suppressing NF-kappaB pathway J Ethnopharmacol 280 159-658
[7]
Leung DY(2021)Effects of chloroform fraction of J Ethnopharmacol 281 655-654
[8]
De Benedetto A(2020) Bulbus on atopic symptoms in a DNCB-induced atopic dermatitis-like skin lesion model and in vitro models. J Ethnopharmacol 249 639-223
[9]
Kubo A(2015)Huang-Lian-Jie-Du extract ameliorates atopic dermatitis-like skin lesions induced by 2,4-dinitrobenzene in mice via suppression of MAPKs and NF-kappaB pathways Skin Pharmacol Phys 28 57-898
[10]
Beck LA(2002)Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis—two randomised controlled trials Allergy 57 219-C704